Cogent Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 10.47 M | $113.08 M | 0.00% | 9.50% |
KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 9.24 M | $99.79 M | -0.22% | 8.39% |
FMR LLC | 11/13/2024 | 8.32 M | $89.85 M | 8.13% | 7.55% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.99 M | $86.31 M | 100.00% | 7.25% |
COMMODORE CAPITAL LP | 11/14/2024 | 7.54 M | $81.43 M | -22.57% | 6.84% |
TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 6.96 M | $75.22 M | 0.00% | 6.32% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2024 | 6.23 M | $67.24 M | 0.00% | 5.65% |
VANGUARD GROUP INC | 11/13/2024 | 5.71 M | $61.72 M | 8.64% | 5.19% |
VR ADVISER, LLC | 11/14/2024 | 5.68 M | $61.39 M | 0.00% | 5.16% |
PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 4.61 M | $49.79 M | 27.19% | 4.18% |
REDMILE GROUP, LLC | 11/14/2024 | 4.48 M | $48.43 M | -6.57% | 4.07% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 4.07 M | $43.91 M | -4.30% | 3.69% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 3.74 M | $40.44 M | 0.00% | 3.40% |
STATE STREET CORP | 11/14/2024 | 3.23 M | $34.90 M | -15.78% | 2.93% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.28 M | $24.64 M | 15.15% | 2.07% |
SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 2.27 M | $24.46 B | -18.32% | 2.06% |
LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 2.00 M | $21.60 M | 100.00% | 1.82% |
SATURN V CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.71 M | $18.50 M | 2.33% | 1.55% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.61 M | $17.43 M | 30.99% | 1.46% |
OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 1.31 M | $14.09 M | 100.00% | 1.18% |
SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.22 M | $13.19 M | 1.26% | 1.11% |
VIVO CAPITAL, LLC | 11/13/2024 | 1.12 M | $12.12 M | -50.00% | 1.02% |
AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 1.00 M | $10.81 M | 0.03% | 0.91% |
FRANKLIN RESOURCES INC | 11/27/2024 | 1.00 M | $11.31 M | 0.01% | 0.91% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 936,576 | $10.12 M | 0.00% | 0.85% |
EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 919,635 | $9.93 M | -34.26% | 0.83% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 878,037 | $9.48 M | 70.91% | 0.80% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 825,793 | $8.92 M | 20.26% | 0.75% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 792,423 | $8.56 M | -14.82% | 0.72% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 790,936 | $8.54 M | 0.00% | 0.72% |
MORGAN STANLEY | 11/14/2024 | 688,894 | $7.44 M | -29.82% | 0.63% |
ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 607,208 | $6.56 M | 1.07% | 0.55% |
WOODLINE PARTNERS LP | 11/14/2024 | 600,576 | $6.49 M | 0.08% | 0.55% |
5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 561,854 | $6.07 M | -28.92% | 0.51% |
WALLEYE CAPITAL LLC | 11/14/2024 | 557,326 | $6.02 M | 100.00% | 0.51% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 501,412 | $5.42 M | 23.40% | 0.46% |
INVESCO LTD. | 11/12/2024 | 494,078 | $5.34 M | 201.33% | 0.45% |
KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 462,188 | $4.99 M | 0.49% | 0.42% |
D. E. SHAW & CO., INC. | 11/14/2024 | 457,228 | $4.94 M | 53.07% | 0.42% |
PROSIGHT MANAGEMENT, LP | 11/14/2024 | 410,830 | $4.44 M | -17.83% | 0.37% |
CRESTLINE MANAGEMENT, LP | 11/13/2024 | 369,763 | $3.99 M | 13.40% | 0.34% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 342,323 | $3.70 M | 8.04% | 0.31% |
CINCTIVE CAPITAL MANAGEMENT LP | 11/14/2024 | 330,419 | $3.57 M | 91.60% | 0.30% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 314,995 | $3.40 M | -58.79% | 0.29% |
BANK OF MONTREAL /CAN/ | 11/13/2024 | 287,610 | $3.13 M | 100.00% | 0.26% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 263,578 | $2.85 M | -19.29% | 0.24% |
NEW LEAF VENTURE PARTNERS, L.L.C. | 11/13/2024 | 250,765 | $2.71 M | 0.00% | 0.23% |
MACQUARIE GROUP LTD | 11/14/2024 | 230,000 | $2.48 M | 0.00% | 0.21% |
HIGHVISTA STRATEGIES LLC | 11/14/2024 | 225,633 | $2.44 M | -19.73% | 0.20% |
ALGERT GLOBAL LLC | 11/12/2024 | 179,025 | $1.93 M | 14.00% | 0.16% |
Cogent Biosciences, Inc.institutional Ownership - FAQ's
During the previous two years, 187 institutional investors and hedge funds held shares of Cogent Biosciences, Inc.. The most heavily invested institutionals were:
Point72 Asset Management, L.P.: 10.47 M
Kynam Capital Management, LP: 9.24 M
FMR LLC: 8.32 M
BlackRock Funding, Inc. /DE: 7.99 M
COMMODORE CAPITAL LP: 7.54 M
TCG Crossover Management, LLC: 6.96 M
110.60% of Cogent Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 129.53 M shares in the last 24 months. This purchase volume represents approximately $1.02 B in transactions.